Tech Company Financing Transactions
Elstar Therapeutics Funding Round
Apple Tree Partners participated in a $39 million Series A funding round for Elstar Therapeutics. The funding round was announced on 1/4/2018.
Transaction Overview
Company Name
Announced On
1/4/2018
Transaction Type
Venture Equity
Amount
$39,000,000
Round
Series A
Investors
Apple Tree Partners (Andreas Loew)
Proceeds Purpose
The funds will be used to expand its growing pipeline and progress several early stage molecules towards the clinic.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
840 Memorial Dr. 4th Floor
Cambridge, MA 02139
USA
Cambridge, MA 02139
USA
Phone
Website
Email Address
Not Recorded
Overview
Elstar Therapeutics is fulfilling the promise of precision cancer immunotherapy through a powerful new approach to generating antibody-based, multi-functional therapeutics. Armed with a unique approach to engaging multiple immune mechanisms, we enable patients to harness their own body to fight cancer.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Andreas Loew
Chief Financial Officer
Patricia Deware
Vice President
Rajeev Chillakuru
Vice President
Thomas Tan
VP - Bus. Development
Peter Williams
Browse more venture capital transactions:
Prev: 1/4/2018: Ecochlor venture capital transaction
Next: 1/4/2018: Critical Diagnostics venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs